
Pint Pharma’s ORLADEYO® Approved to Prevent HAE Attacks in Peru
Pint Pharma is pleased to announce that ORLADEYO® (berotralstat) has been approved by the General Directorate of Medicines, Supplies and Drugs (DIGEMID) in Peru for daily oral use in the prophylaxis of hereditary angioedema (HAE) attacks in adult and pediatric…












